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Summary  13 
Hepatitis C virus (HCV) represents a significant global health burden. Viral replication is thought to 14 
occur in close association with remodelled host cell membranes with non-structural protein 4B (NS4B) 15 
being a key player in this process. NS4B is a poorly characterized integral membrane protein, which 16 
has been reported to be palmitoylated at its carboxy-terminal end. In order to extend this observation 17 
and to establish a functional role for NS4B palmitolylation, we sought to determine the status of this 18 
post-translational modification when the protein was expressed as part of a functional viral replicase. 19 
We performed direct metabolic labelling and polyethylene glycol-maleimide palmitoylation reporter 20 
assays on NS4B expressed in cells containing subgenomic replicons and infectious viral RNA. In a 21 
vaccinia virus-based expression system NS4B palmitoylation was detected in a genotype-dependent 22 
manner. However, in spite of the high sensitivity of the methods used, no NS4B palmitoylation was 23 
found in physiologically more relevant systems. Thus, NS4B palmitoylation is most likely dispensable 24 
for HCV RNA replication.  25 
  26 
Text  27 
Hepatitis C virus (HCV) infects an estimated 170 million individuals worldwide, and is responsible for 28 
significant liver related morbidity and mortality. As member of the recently classified hepacivirus 29 
genus, it is a positive strand enveloped RNA virus encoding both structural and non-structural (NS) 30 
proteins within a single open reading frame, translation of which is driven by an internal ribosome 31 
entry site. Replication of the HCV genome requires remodelling of host-cell derived ER membranes to 32 
form the viral replication factory (vRF), a membranous compartment that sequesters viral and host 33 
cell proteins necessary for RNA synthesis and protects replicative intermediates from anti-viral host 34 
activity (reviewed in (Paul et al., 2014)). A key viral protein involved in membrane remodelling events 35 
is NS4B (Egger et al., 2002). While the full structure of NS4B has yet to be solved, the protein is believed 36 
to possess two amino-terminal amphipathic helices (AH), four central trans-membrane domains and 37 
two α-helices in the carboxy-terminal domain (reviewed in (Gouttenoire et al., 2010a)). NS4B self-38 
interacts via multiple determinants, which is required for its function in vRF biogenesis (Gouttenoire 39 
et al., 2010b;Paul et al., 2011).  Expressed alone, NS4B induces the formation of single membrane 40 
vesicles within cells, but needs to be expressed in the context of the NS3-5B replicase to recapitulate 41 
the same membrane changes found in infected cells (Romero-Brey et al., 2012). One feature of NS4B 42 
that may be important for its function is palmitoylation, a post-translational modification mapped to 43 
two cysteine residues found at the C-terminal end of the protein (Yu et al., 2006)(Fig 1a).  44 
The aim of this study was to extend the original observations regarding NS4B palmitoylation by 45 
quantifying its occurrence when the protein is expressed in a context that supports HCV RNA 46 
replication, thus establishing its likely importance in replication complex (RC) formation. In the first 47 
instance, we expressed NS4B from two different T7-driven protein expression systems using 48 
constructs encoding NS4B with an HA- epitope tag inserted after residue 38, either in the context of a 49 
JFH-1 NS3-5B polyprotein, or as a single protein derived from isolates JFH1, Con1 and H77. Analysis of 50 
cell lysates after anti-HA pull down confirmed that the tag allowed specific purification of NS4B in all 51 
cases (Fig. 1b). Next we sought to determine the NS4B palmitoylation status by metabolic labelling 52 
with tritiated palmitate and compared a cell line that stably overexpresses T7 RNA polymerase (Lunet-53 
T7) to the transient T7 delivery by infection of naïve Lunet cells with a modified vaccinia virus (MVA-54 
T7) as performed previously (Yu et al., 2006). Expression of Bet3 served as a positive control for 55 
palmitoylation, while expression of HA-tagged apolipoprotein E (ApoEHA) was used to control for non-56 
specific background labelling. A total of 3.5 x 105 cells/well were seeded into 6-well plates and 57 
transfected with expression vectors 24 h later. In case of Vaccinia virus-mediated T7 expression, cells 58 
were infected with MVA-T7 90 min prior to transfection of plasmids. Sixty eight hours post seeding, 59 
cells were starved for 1 h in medium with delipidated FCS and subsequently labelled with 80 µCi/ml 60 
[9,10-3H(N)]-palmitate for 3 h. In parallel we labelled total proteins, supplying cells with 20 µCi/ml 61 
[35S]-Met/Cys. Cells were lysed in RIPA buffer (50mM Tris pH 7.5; 150 mM NaCl; 1% NP-40; 0.5% 62 
deoxycholate; 0.1% SDS; 1x protease inhibitors) and immuno-purified using anti-HA or anti-Myc 63 
agarose beads for NS4BHA, ApoEHA and Bet3Myc, respectively. After elution of proteins in non-reducing 64 
sample buffer they were separated by SDS-PAGE, blotted onto PVDF membranes and analysed with a 65 
β-imager 2000 (Biospace) to detect the 3H radioactive signal. Detection of [35S] signals by 66 
autoradiography confirmed successful immunoprecipitation of all proteins and revealed comparable 67 
expression and recovery of NS4B in Lunet-T7 cells and MVA-T7 infected Lunet cells (Fig. 1d). 68 
Furthermore, in both experimental conditions we detected palmitoylation of Bet3 as reported earlier 69 
(Turnbull et al., 2005) (Fig. 1e). Intriguingly, while palmitoylation of NS4B was not detectable in Lunet-70 
T7 cells, we observed robust 3H radioactive signals upon MVA-T7 mediated NS4B expression. 71 
Importantly, also the negative control ApoE was found to be profoundly palmitoylated in the latter 72 
condition, suggesting a strong influence on protein palmitoylation by MVA infection. Quantitation of 73 
these signals further allowed us to estimate the degree of NS4B radiolabelling ([3H] band intensity) by 74 
normalizing to the total amount of immunopurified protein ([35S] band intensity divided by number of 75 
Met+Cys residues) (Fig. 1C). This analysis revealed a substantial increase in palmitoylation of NS4B, 76 
when expressed as a single protein, but also in case of the negative control protein ApoE, in the MVA-77 
T7 experimental condition. Thus, at least under given experimental conditions, vaccinia virus 78 
stimulated non-specific palmitoylation of proteins.  79 
To avoided further use of MVA-T7 driven protein expression we adopted a more physiologically 80 
relevant system, performing metabolic labelling with tritiated palmitate on cells that stably replicate 81 
a subgenomic JFH RNA encoding an HA-epitope in the N-terminal region of NS4B (Paul et al., 2013). 82 
The ER-resident protein calnexin (CANX) served as an additional positive control for palmitoylation 83 
(Lakkaraju et al., 2012). The [3H]-palmitate labelling and subsequent immunocapture of proteins was 84 
performed as described above. Western blot analysis with mono-specific antibodies revealed that all 85 
proteins were specifically enriched after IP (Fig. 2a). However, no NS4B palmitoylation was detected 86 
in contrast to robust signals for the positive controls CANX and Bet3 (Fig. 2b). 87 
In addition to our attempts to directly visualize palmitoylation by metabolic labelling, we assessed this 88 
modification using an established chemical-based procedure (Fig 3) (Roth et al., 2006). In this assay, 89 
n-ethylmaleimide (NEM) is used to irreversibly block all free sulfhydryl groups on cysteine residues. 90 
Hydroxylamine is subsequently used to specifically reduce the thioester bonds linking cysteine 91 
residues to palmitic acid, making them susceptible to modification with PEG-maleimide, detectable 92 
through a reduction in electrophoretic mobility of PEG-modified proteins (Fig. 3a). 93 
To facilitate detection of NS4B, a baculovirus delivery system was initially used to drive high level 94 
production of a Con1 subgenomic replicon transcript in the hepatocyte cell line HepG2. A 25cm2 flask 95 
seeded 24 h earlier with 7.5 x 105 cells was transduced for 24 h with 6.25 x 106 pfu/ml of BACrep 96 
5.1neo and BACtTA (McCormick et al., 2004), then lysed in 100 µl TES buffer (50mM Tris [pH 7.4], 97 
150mM NaCl, 5mM EDTA, 0.5% Tx100, 0.1% SDS) containing 10mM NEM and 2x protease inhibitor. 98 
After clarification of the supernatant by centrifugation, SDS was added to a final concentration of 0.5% 99 
(w/v) and the reactions left overnight at 4°C. Remaining NEM was removed by 3 rounds of methanol 100 
chloroform precipitation and the protein pellet dissolved in 20 µl PR buffer (4% SDS, 50mM Tris [pH 101 
7.4], 5mM EDTA).  Half was added to 40µl 1M hydroxylamine [pH8.0], while the remaining half was 102 
added to 40µl 1M Tris [pH 8.0] and samples incubated for 1 h at 25°C.  Each reaction was subjected to 103 
a further methanol chloroform precipitation step to recover protein, the pellet resuspended in 20 µl 104 
PR buffer and further 20 µl of 10% (w/v) PEG-maleimide in TES lysis buffer added.  After incubation at 105 
37°C for 1 h, samples were re-precipitated and analysed by Western blot with mono-specific 106 
antibodies. No discernible difference could be seen between the ratio of PEG-conjugated and 107 
unconjugated NS4B in the hydroxylamine versus Tris-treated lysates, indicating that the protein was 108 
not palmitoylated (Fig 3b). In contrast palmitoylation of a control protein, Bet3, was readily detected.  109 
In case the inability to detect NS4B palmitoylation using the PEG-maleimide assay was a consequence 110 
of expressing the replicon transcript in a cell line unable to support RNA replication, or was specific to 111 
the Con-1 isolate, we decided to extend our analysis. Therefore a similar assay was performed on a 112 
Huh7.5 cell line stably carrying the genotype 1a H77 replicon, and on Huh7.5 cells transfected 96 hours 113 
earlier with an infectious genotype 2a virus genome. In order to enhance specific detection of NS4B 114 
we modified the assay such that cells from a confluent 75cm2 flask were initially lysed in 0.8ml Tx114 115 
lysis buffer (150mM NaCl, 10mM Tris [pH7.4], 2% Tx114, 1mM EDTA, 2 x complete protease inhibitor) 116 
and membrane associated proteins were recovered by phase separation prior to the addition of 10mM 117 
NEM in TES lysis buffer. Neither upon HCV genome transfection, nor in context of replicating H77 118 
subgenomic RNA, were any signs of NS4B palmitoylation detected (Fig. 3c, d), despite clear evidence 119 
of palmitoylation of the Bet3 control each time the assay was run. Furthermore core palmitoylation, 120 
reported to occur on cysteine 172 (Majeau et al., 2009), was also visualized using this assay (Fig. 3c), 121 
albeit at a lower level than observed for Bet3. 122 
In summary, we do not find evidence for palmitoylation of NS4B in any physiologically relevant setting. 123 
This is at variance to the report by Yu and coworkers, who reported palmitoylation of NS4B (Yu et al., 124 
2006). One reason for this discrepancy might be differences in experimental design. Yu and colleagues 125 
entirely relied on infection with a recombinant vaccinia virus to mediate T7-driven expression of NS4B 126 
as a single protein. However, VACV infection considerably affects intracellular membrane homeostasis 127 
(Krijnse-Locker et al., 2013)  and it is possible that this might promote “false-positive” NS4B 128 
palmitoylation. Indeed, our data support the notion that MVA infection stimulates non-specific 129 
palmitoylation of NS4B and ApoE (Fig. 1E).  130 
Another difference is the use of chemical procedures to quantitate palmitoylation. Both investigations 131 
employed maleimide-based chemistry to target cysteine residues for PEGylation. In our study, 132 
PEGylation subsequent to hydroxylamine treatment was used to indicate palmitoylation of proteins, 133 
but in the study by Yu et al the presence of a palmitoyl group was instead considered to protect the 134 
protein from palmitoylation.  Follow-up work we have undertaken is consistent with the notion that 135 
hydroxylamine specifically reduces thioester bonds without reducing other oxidized forms of Cys. In 136 
contrast a ‘mild’ dithiothreitol treatment, used by Yu and colleagues prior to incubating their protein 137 
samples with PEG-maleimide, acts as a non-specific reducing agent in our hands (Suppl. Fig. 1).  As a 138 
consequence, differences in NS4B PEGylation observed by Yu and colleagues may have reflected the 139 
oxidized status of the cysteine residues in NS4B rather than their palmitoylation status. 140 
In theory, a key test to establish whether NS4B palmitoylation is necessary would be to determine 141 
whether a modified version of the protein lacking the C-terminal cysteine residues could support 142 
replication. Indeed, Yu et al undertook such analysis and concluded that while cysteine 257 was 143 
dispensable for replication, cysteine 261 was absolutely necessary (Yu et al., 2006). However, the 144 
interpretation of these findings is hampered by the fact that cysteine 261 is the P1 residue of the 145 
NS4B-5A cleavage site, a point acknowledged by the authors at the time. A more recent study by us 146 
has shown that the rate of cleavage of this boundary is critical for RNA replication (Herod et al., 2012). 147 
Given the central role that cysteine at the P1 position has in allowing efficient recognition by the NS3 148 
protease, it is technically challenging to separate effects caused by polyprotein cleavage or possible 149 
palmitoylation defects when introducing mutations at this site. Overcoming this hurdle would require 150 
an as yet unavailable trans-complementation system that supports HCV RNA replication 151 
independently from polyprotein cleavage.  152 
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Figure legends 158 
Figure 1: The non-palmitoylated status of NS4B is altered upon MVA-T7 driven protein expression. 159 
Shown is a sequence alignment of the carboxy-terminal region of NS4B (amino acids 254-261) for the 160 
three HCV isolates used in this study, with asterisks indicating cysteine residues previously reported 161 
to be palmitoylated (a). Huh7-Lunet/T7 cells transfected with pTM expression plasmids as indicated 162 
on the top were harvested 24 hours after transfection and NS4B was immunocaptured with HA-beads. 163 
Western Blot analysis with mono-specific antibodies indicated on the right is shown in (b). After 164 
transfection of cells with pTM and control expression plasmids as indicated in (c), metabolic labelling 165 
with either [3H]-palmitate or [35S]-Met/Cys was performed. Proteins were purified by HA-, or Myc-166 
specific IP and after SDS-PAGE the [35S]-labelled proteins visualized by autoradiography (d) and the 167 
[3H]-signal was detected using a β-imager (e). 33% of the IP fraction was loaded in each lane and 168 
molecular weight standards are indicated on the left of each blot. (c) Relative palmitoylation of the 169 
respective protein was calculated as a ratio of [3H]/[35S] signal normalized for the sum of Met/Cys 170 
residues in the given protein and assuming a single palmitoylation site. Values that are normalized to 171 
the Bet3 positive control expressed in Lunet T7 cells are shown. 172 
Figure 2: Absence of detectable palmitoylation of NS4B purified from active HCV replication 173 
complexes. Huh7-Lunet cells overexpressing calnexin-HA (CANXHA), or containing a JFH-1 wildtype 174 
replicon (NS4Bwt) or a JFH-1 replicon encoding HA-tagged NS4B (NA4BHA), or transfected with 175 
expression vectors encoding HA-tagged apolipoprotein E (ApoEHA) or the myc-tagged Bet3 positive 176 
control protein (Bet3Myc), were metabolically labelled with [3H]-palmitate followed by HA- or Myc-177 
specific IP. Western blot analyses of unlabelled control samples that were processed in parallel are 178 
shown in (a). Conjugation of radioactive [3H]-palmitate to proteins was revealed using a beta imager 179 
and is depicted in (b). Molecular weight standards are indicated on the left of each blot. 180 
Figure 3: Assessing palmitoylation of NS4B in HCV replication complexes by maleimide-based 181 
chemistry. The illustration (a) shows the step-wise chemical reaction these NS4B proteins were 182 
subjected to. In this assay, free sulfhydryl groups are first blocked by n-ethylmaleimide (NEM). 183 
Enhanced conjugation to PEG-maleimide subsequent to treatment with hydroxylamine versus 184 
treatment with Tris indicates palmitoylation, visualized as an increase in the ratio of PEG-modified 185 
protein to unmodified protein. Western blots show the results on NS4B palmitoylation from cells 186 
expressing genotype 1b (b), 2a (c) and 1a (d) HCV polyproteins. Polyprotein expression was achieved 187 
using a RNA polymerase II-based baculovirus delivery system to introduce the FK5.1neo transcript into 188 
HepG2 cells (b), by transfection of an infectious full length genotype 2a transcript (containing a 189 
chimeric JFH-1[nt1-77]/J6[nt 78-341] 5’UTR and encoding a J6/JFH-1 polyprotein equivalent to Jc1) 190 
(Pietschmann et al., 2006) into Huh7.5 cells (c), or use of a stable Huh7.5-derived cell line carrying the 191 
H77 H/SG-Neo(L+I) replicon(d). HepG2 (b) or Huh7.5 (c, d) cells transfected with the plasmid pBet3-192 
myc were used as a positive control in each assay. In the experimental group transfected with the 193 
genotype 2a infectious HCV transcript, assessment of core palmitoylation was included as a further 194 
control (c). Lanes 1 and 2 represent the pBet3-myc transfected cell lysates, lanes 3 and 4 the HCV 195 
lysates, with proteins having been treated with Tris (lanes 1, 3) or hydroxylamine (lanes 2, 4) prior to 196 
incubation with PEG maleimide. The arrows on the blots indicate the position of unmodified protein 197 
and the asterisks indicate the position of PEG modified protein. Molecular weight standards are 198 
indicated on the left of each blot. 199 
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